Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2003-04-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0931430100PMID 12719541PMCID PMC156324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.

  2003cited by this paper
• PRCC-TFE3 Renal Carcinomas: Morphologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of an Entity Associated With the t(X;1)(p11.2;q21)

  2002cited by this paper
• Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.

  2002cited by this paper
• β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor

  2002cited by this paper
• Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development

  2002cited by this paper
• Understanding familial and non-familial renal cell cancer.

  2002cited by this paper
• Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice.

  2001cited by this paper
• Impairment of MAD2B–PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas

  2001cited by this paper
• The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

  2001cited by this paper
• Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.

  2001cited by this paper
• PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation.

  2001cited by this paper
• Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.

  2001cited by this paper
• Induction of Melanocyte-specific Microphthalmia-associated Transcription Factor by Wnt-3a*

  2000cited by this paper
• Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins

  2000cited by this paper
• Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway.

  2000cited by this paper
• Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints.

  2000cited by this paper
• The bHLH-Zip transcription factor Tfeb is essential for placental vascularization.

  1998cited by this paper
• A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.

  1997cited by this paper
• Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma

  1997cited by this paper
• Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.

  1996cited by this paper
• Pathogenesis of renal cell tumors: A (cyto)-genetic model

  1996cited by this paper
• The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene.

  1996cited by this paper
• Transcriptional activation of the melanocyte-specific genes by the human homolog of the mouse Microphthalmia protein.

  1995cited by this paper
• Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations.

  1995cited by this paper
• Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene

  1994cited by this paper
• Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene

  1994cited by this paper
• microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.

  1994cited by this paper
• Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences

  1994cited by this paper
• A radiation hybrid map of 506 STS markers spanning human chromosome 11

  1994cited by this paper
• Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator

  1994cited by this paper
• TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation

  1993cited by this paper
• Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein.

  1993cited by this paper
• High affinity DNA-binding Myc analogs: recognition by an alpha helix.

  1993cited by this paper
• High affinity DNA-binding Myc analogs: Recognition by an α helix

  1993cited by this paper
• Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors.

  1991cited by this paper
• The leucine zipper of TFE3 dictates helix-loop-helix dimerization specificity.

  1991cited by this paper
• A dominant negative form of transcription activator mTFE3 created by differential splicing.

  1991cited by this paper
• A helix-loop-helix protein related to the immunoglobulin E box-binding proteins

  1990cited by this paper
• TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif.

  1990cited by this paper
• Molecular cloning : a laboratory manual. Cold Spring Harbor, NY

  1989cited by this paper
• Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias.

  1986cited by this paper
• Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

  1986cited by this paper
• Translocation of an immunoglobulin kappa locus to a region 3' of an unrearranged c-myc oncogene enhances c-myc transcription.

  1983cited by this paper
• Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma.

  1983cited by this paper
• Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.

  1983cited by this paper
• How do eucaryotic ribosomes select initiation regions in messenger RNA?

  1978cited by this paper

• TFE-Altered Renal Cell Carcinoma: A Contemporary Review With Practical Insights and Diagnostic Pearls for Surgical Pathologists.

  2026cites this paper
• Central Role of MITF/TFE Family Transcription Factors in Diverse Clear and Granular Cell Tumors.

  2026cites this paper
• The role of long non‐coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implications

  2025cites this paper
• Paediatric renal tumors: An insight into molecular characteristics, histomorphology and syndromic association

  2025cites this paper
• Centrosome dysfunction and autophagy dysregulation in renal cell carcinoma: Implications for tumor progression and therapy.

  2025cites this paper
• Combined Effect of Conventional Chemotherapy with Epigenetic Modulators on Glioblastoma

  2025cites this paper
• TFE3/TFEB Altered Renal Cell Carcinomas in End-Stage Renal Disease Setting: A Single Institution Clinicopathological Study of 4 Cases.

  2025cites this paper
• MiT family translocation carcinomas of the kidney and related entities

  2025cites this paper
• The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.

  2024cites this paper
• Role of long non‑coding RNA leucine‑rich repeat containing 75 A‑antisense RNA1 in the invasion and progression of renal cell carcinoma

  2024cites this paper
• Transcription factor EB as a key molecular factor in human health and its implication in diseases

  2023cites this paper
• PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated with Lipoma and a Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma.

  2023cites this paper
• Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment

  2023cites this paper
• Prognosis and Clinicopathological Characters of Adult TFEB-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases.

  2023cites this paper
• Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer

  2023cites this paper
• A review of neoplasms with MITF/MiT family translocations.

  2022cites this paper
• Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

  2022cites this paper
• Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease

  2022cites this paper
• Obesity accelerates immune evasion of non-small cell lung carcinoma via TFEB-dependent upregulation of Siglec-15 and glycolytic reprogramming.

  2022cites this paper
• TRPML1 and TFEB, an Intimate Affair.

  2022cites this paper
• RETRACTED: Lysosomes in Stem Cell Quiescence: A Potential Therapeutic Target in Acute Myeloid Leukemia

  2022cites this paper
• Renal Cell Carcinoma Associated with t (6;11) Translocation/TFEB Gene Fusion: A Case Report and Review of Literature.

  2022cites this paper
• Comprehensive study of nine novel cases of TFEB‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression

  2022cites this paper
• Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.

  2021cites this paper
• A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers.

  2021cites this paper
• Translocation carcinomas of the kidney

  2021cites this paper
• The role of MiT/TFE family members in autophagy regulation.

  2021cites this paper
• Undifferentiated Embryonal Sarcoma of the Liver With Rhabdoid Morphology Mimicking Carcinoma: Expanding the Morphologic Spectrum or a Distinct Variant?

  2021cites this paper
• Transcription factor EB regulates cardiovascular homeostasis.

  2021cites this paper
• The Oncogene Transcription Factor EB Regulates Vascular Functions

  2021cites this paper
• User guide to MiT‐TFE isoforms and post‐translational modifications

  2020cites this paper
• The role of TFEB in tumor cell autophagy: Diagnostic and therapeutic opportunities.

  2020cites this paper
• Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies

  2020cites this paper
• TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia.

  2020cites this paper
• MALAT1 Long Non-Coding RNA: Functional Implications

  2020cites this paper
• TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1

  2020cites this paper
• Multifaceted activities of transcription factor EB in cancer onset and progression

  2020cites this paper
• The anti-tumor agent, Dp44mT, promotes nuclear translocation of TFEB via inhibition of the AMPK-MTORC1 axis.

  2020cites this paper
• Contributions of genetics to the evolution of the diagnostic classification of renal cell neoplasia: a personal perspective.

  2020cites this paper
• Pediatric Solid Tumors

  2020cites this paper
• Evaluating and modulating TFEB in the control of autophagy: toward new treatments in CNS disorders

  2020cites this paper
• Requirement of FLCN tumor suppressor gene for mTORC1-mediated inhibition of TFE3 transcriptional activity

  2020cites this paper
• Long non‐coding RNAs in motor neuron development and disease

  2020cites this paper
• Targetable gene fusions and aberrations in genitourinary oncology

  2020cites this paper
• Tissue-Based Immunohistochemical Markers for Diagnosis and Classification of Renal Cell Carcinoma

  2020cites this paper
• TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response

  2020cites this paper
• TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease

  2019cites this paper
• The role of MITF in regulating transcriptional cell states in melanoma

  2019cites this paper
• TFEB Expression Profiling in Renal Cell Carcinomas

  2019cites this paper
• TFEB Mediates Immune Evasion and Resistance to mTOR Inhibition of Renal Cell Carcinoma via Induction of PD-L1

  2019cites this paper
• The Role of MALAT 1 in Cancer

  2019cites this paper
• Management of Non-Clear Cell Renal Cell Carcinoma

  2019cites this paper
• The Metabolic Basis of Kidney Cancer.

  2019cites this paper
• Histological and molecular characterization of TFEB-rearranged renal cell carcinomas

  2019cites this paper
• NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma

  2019cites this paper
• MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer.

  2019cites this paper
• Microphthalmia family of transcription factors associated renal cell carcinoma

  2019cites this paper
• Structural mechanism of a Rag GTPase activation checkpoint by the lysosomal folliculin complex

  2019cites this paper
• Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors

  2019cites this paper
• Clinical and morphological features, immune profile of renal cell tumors with clear cytoplasm

  2019cites this paper
• Kidney: Renal cell carcinoma with t(6;11)(p21;q12) MALAT1/TFEB

  2018cites this paper
• Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression

  2018cites this paper
• Alpha gene upregulates TFEB expression in renal cell carcinoma with t(6;11) translocation, which promotes cell canceration.

  2018cites this paper
• Long non-coding RNA and Polycomb: an intricate partnership in cancer biology.

  2018cites this paper
• Non-immunoglobulin AID target loci share unique features with immunoglobulin genes

  2018cites this paper
• Comprehensive study of three novel cases of TFEB‐amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome

  2018cites this paper
• The genomics of renal cell carcinoma and its role in renal mass biopsy

  2018cites this paper
• Emerging roles and regulation of MiT/TFE transcriptional factors

  2018cites this paper
• MALAT1 as a new biomarker in cancer biology

  2018cites this paper
• t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma

  2018cites this paper
• MALAT1: a potential biomarker in cancer

  2018cites this paper
• Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1–Livin protein interaction

  2017cites this paper
• Modeling Alveolar Soft Part Sarcoma Unveils Novel Mechanisms of Metastasis.

  2017influential citation
• Chromosomes and Chromosomal Instability in Human Cancer

  2017cites this paper
• Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors.

  2017cites this paper
• TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management

  2017cites this paper
• Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?

  2017cites this paper
• Nephron-sparing surgery in the treatment of pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions.

  2017cites this paper
• Renal cell carcinoma with t(6,11): A case report and review of literature

  2017influential citation
• The long noncoding RNA Malat1: Its physiological and pathophysiological functions

  2017cites this paper
• Multistep regulation of TFEB by MTORC1

  2017cites this paper
• Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics

  2017cites this paper
• A phase 1 study of the c‐Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)

  2017cites this paper
• The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

  2017cites this paper
• Letter to the editor

  2017influential citation
• Recurrent MALAT1–GLI1 oncogenic fusion and GLI1 up‐regulation define a subset of plexiform fibromyxoma

  2016cites this paper
• Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling

  2016influential citation
• MALAT1 long non-coding RNA in cancer.

  2016cites this paper
• Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma.

  2016cites this paper
• Neoplasms of the Kidney

  2016cites this paper
• TFEB at a glance

  2016cites this paper
• Renal cell carcinomas with t(6;11) translocation: identification of a novel Alpha-TFEB fusion point

  2016cites this paper
• TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity

  2016cites this paper
• Das Translokationskarzinom

  2016cites this paper
• Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma

  2016cites this paper
• Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas.

  2016cites this paper
• Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer

  2016cites this paper
• High-Throughput Analysis of Noncoding RNAs: Implications in Clinical Epigenetics

  2016cites this paper
• TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress.

  2016cites this paper
• Noncoding RNAs: New Players in Cancers.

  2016cites this paper